Literature DB >> 34571266

EncephalApp Stroop Test validation for the screening of minimal hepatic encephalopathy in Brazil.

Marlone Cunha-Silva1, Fernando L Ponte Neto2, Priscila S de Araújo2, Lucas V Pazinato2, Raquel D Greca2, Tirzah M L Secundo2, Marcello R Imbrizi2, Leonardo T Monici2, Tiago Sevá-Pereira2, Daniel F Mazo3.   

Abstract

INTRODUCTION AND
OBJECTIVES: The EncephalApp Stroop Test was developed to more easily diagnose minimal hepatic encephalopathy (MHE). A cut-off of >274.9sec (ONtime+OFFtime) reached a 78% sensitivity and 90% specificity in the validation study, but it has been poorly studied in Brazil. We aim to analyze the usefulness of this diagnostic method and to describe a cut-off value to screen MHE in Brazil.
METHODS: In this cross-sectional and single-center study, three positive psychometric tests defined the diagnosis of MHE as the gold standard. We evaluated gender, age, education, familiarity with smartphones, etiology of cirrhosis, Child-Pugh/MELD scores, and previous hepatic encephalopathy (HE). Healthy controls and patients without HE were compared for the task validation. The Chi-square and Mann-Whitney tests, logistic regression analysis, and ROC curves were used for statistical evaluation.
RESULTS: We included 132 patients with cirrhosis (61% male) and 42 controls (62% male) around 51y. Sixty-three were diagnosed with MHE on psychometric tests and 23 had clinical HE. Viral hepatitis (38%) was the major etiology of cirrhosis. The median MELD was 10 and Child-Pugh A was more frequent (70%). There was no significant difference in test results between controls and patients without HE. There was also no influence of gender, age, education, and familiarity with smartphones in the test results. Child-Pugh A was associated with MHE (p=0.0106). A cut-off of >269.8sec (ONtime+OFFtime) had an 87% sensitivity and 77% specificity to detect MHE (p=0.002).
CONCLUSION: This is a valid and reliable tool for screening MHE. However, optimal cut-off values need to be validated locally.
Copyright © 2021 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Cirrhosis; Cognitive dysfunction; Hepatic encephalopathy; Stroop test

Mesh:

Year:  2021        PMID: 34571266     DOI: 10.1016/j.aohep.2021.100543

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  2 in total

Review 1.  A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Hepatic Encephalopathy and Clostridioides difficile Infection in Patients With Cirrhosis.

Authors:  Kyaw Min Tun; Annie S Hong; Kavita Batra; Yassin Naga; Gordon Ohning
Journal:  Cureus       Date:  2022-05-31

Review 2.  Fecal Microbiota Transplantation in Decompensated Cirrhosis: A Systematic Review on Safety and Efficacy.

Authors:  Annie S Hong; Kyaw Min Tun; Jenny M Hong; Kavita Batra; Gordon Ohning
Journal:  Antibiotics (Basel)       Date:  2022-06-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.